Searchable abstracts of presentations at key conferences in endocrinology

ea0063p795 | Thyroid 2 | ECE2019

Effect of vitamin D supplementation on cardiovascular indices in Graves’ disease. A randomized clinical trial

Grove-Laugesen Diana , Malmstroem Sofie , Ebbehoj Eva , Riis Anne Lene , Watt Torquil , Hansen Klavs Wurgler , Rejnmark Lars

Background: Risk of cardiovascular disease (CVD) and mortality is increased in Graves’ disease (GD) even years after initial diagnosis and treatment. The mechanisms are incompletely understood. Vitamin D insufficiency is associated with an increased risk of CVD and has been reported to occur frequently in GD. Pulse wave velocity (PWV) and blood pressure (BP) are important predictors of CVD. We performed a clinical trial, testing whether vitamin D supplementation affects P...

ea0070aep861 | Thyroid | ECE2020

How will my life with Graves’ disease be? Two years of serial, longitudinal follow-up of thyroid-related quality of life in patients with Graves’ disease

Grove-Laugesen Diana , Karkov Cramon Per , Ebbehoj Eva , Würgler Hansen Klavs , Rejnmark Lars , Watt Torquil

Objectives: Quality of life (QoL) is severely affected in Graves’ disease (GD) but long-term longitudinal assessment of QoL is lacking. Furthermore, whether QoL is comparable to controls after treatment of GD is unclear. For the first time, we present serial, longitudinal data on thyroid-related QoL during 24 months of follow-up in a cohort of newly diagnosed GD patients. In addition, we compare QoL in GD and controls.Methods: All patients were tre...

ea0070aep1094 | Hot topics (including COVID-19) | ECE2020

Identification of thyroid disease in pregnant women varies by analytical method and type of thyroid function test

Linding Andersen Stine , Astrup Christensen Peter , Knøsgaard Louise , Andersen Stig , Handberg Aase , Bo Hansen Annebirthe , Vestergaard Peter

Objective: Physiological alterations challenge the assessment of maternal thyroid function in pregnancy. It remains uncertain how the reference ranges vary by week of pregnancy, and how the classification of maternal thyroid disease vary by analytical method and type of thyroid function test.Method: Consecutively collectedserum samples from 6.282 pregnant women in the North Denmark Region, 2011–2013, were used for the measurement of thyrotropin (TS...

ea0020p486 | Obesity and Metabolism | ECE2009

The effect of weight loss on serum mannose binding lectin levels

Hoeyem Pernille H , Bruun Jens M , Pedersen Steen B , Richelsen Bjoern , Christiansen Jens S , Hansen Troels K

Background: High levels of mannose-binding lectin (MBL), an activator of complement, have been associated with increased mortality and risk of albuminuria in patients with type 2 diabetes. It is not known if MBL is synthesized in human adipose tissue and the effects of weight loss and changes in insulin sensitivity on MBL levels have been poorly elucidated.Methods: Of 36 nondiabetic obese subjects received a very low-calorie diet (VLCD) of 800 kcal/day f...

ea0081ep855 | Reproductive and Developmental Endocrinology | ECE2022

Maternal prolactin-levels in pregnancy and offspring body composition at 7 years. Odense Child Cohort

Pelck Hansen Freja , Grontved Anders , Jensen Richard C , D Hojsager Frederik , Brandslund Ivan , Boye Henriette , Jensen Tina Kold , Andersen Marianne , Glintborg Dorte

Background: Prolactin is associated with metabolic risk inside and outside of pregnancy. Maternal prolactin levels could be associated with offspring body composition.Aim: To investigate if maternal prolactin-levels were linked to offspring body composition at seven years of age.Design: Prospective observational cohort study (the Odense Child Cohort).Methods: Maternal fasting blood samples were assessed durin...

ea0063gp25 | Calcium and Bone 1 | ECE2019

Impact of chronic hypoparathyroidism on health-related quality of life, symptoms, employment, and relationships: findings from a 13-country patient survey

Bollerslev Jens , Bent-Ennakhil Nawal , Chen Kristina , Clarke Bart L , Dahl-Hansen Helen , Germak John , Gibson Katie , Glenister Elizabeth , Judge Davneet , Marelli Claudio , Siggelkow Heide

Significant knowledge gaps exist regarding the humanistic effects of hypoparathyroidism, a rare, debilitating disorder. We report results from a global survey to characterise the burden of hypoparathyroidism from the patient perspective. An anonymous survey was conducted in patients with uncontrolled chronic hypoparathyroidism (as determined by patients’ report of persistent symptoms and/or poorly controlled calcium levels as told by their physician) despite receiving con...

ea0035p513 | Endocrine disruptors | ECE2014

Di-ethylhexyl-phthalate is metabolised by human thyroid cells and may influence thyroglobulin secretion

Hansen Juliana Frohnert , Brorson Marianne Moller , Hartoft-Nielsen Marie-Louise , Boas Malene , Main Katharina M , Frederiksen Hanne , Hofman-Bang Jacob , Rasmussen AEse Krogh , Feldt-Rasmussen Ulla

Introduction: Phthalates are suspected to influence thyroid function in epidemiologic and experimental animal studies. The aim of the study was to investigate the ability of primary human thyroid cell cultures to metabolise phthalates and a possible concentration-dependent response of phthalates on thyroglobulin (Tg) secretion.Methods: Human thyrocytes obtained from thyroidectomies were cultured to confluent monolayers. These were exposed to DEHP in conc...

ea0070aep158 | Bone and Calcium | ECE2020

Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: European subanalysis of a global patient survey

Siggelkow Heide , Germak John , Marelli Claudio , Chen Kristina , Dahl-Hansen Helen , Glenister Elizabeth , Bent-Ennakhil Nawal , Judge Davneet , Mycock Katie , Clarke Bart L

Although chronic hypoparathyroidism is known to negatively affect health-related quality of life (HRQoL), burden of illness is less well defined in patients whose disease is not adequately controlled on conventional therapy. We report burden of illness for the European subset of a patient survey in 13 countries globally. 398 adults with chronic hypoparathyroidism not adequately controlled on conventional therapy (recruited by treating physician or patient association) complete...

ea0031p328 | Steroids | SFEBES2013

19F-magnetic resonance spectroscopy as a tool to quantify 11β-hydroxysteroid dehydrogenase activity in vivo

Naredo-Gonzalez Gregorio , Jansen Maurits , Upreti Rita , Semple Scott , Merrifield Gavin , Sutcliffe Oliver , Hansen Michael , Marshall Ian , Andrew Ruth , Walker Brian

Non-invasive methods to measure enzyme activity in vivo can provide a useful tool for the development of selective inhibitors. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), a reductase enzyme that amplifies active intracellular glucocorticoid levels, has been shown in obese patients using invasive tools (biopsy, microdialysis and arteriovenous sampling with stable isotope tracers). 11β-HSD1 inhibitors are efficacious in...

ea0014p67 | (1) | ECE2007

Intravenous constant ghrelin infusion in healthy young men: sustained cardiovascular effects of supraphysiological ghrelin levels

Vestergaard Esben Thyssen , Andersen Niels Holmark , Hansen Troels Krarup , Rasmussen Lars Melholt , Moller Niels , Sorensen Keld , Sloth Erik , Christiansen Jens Sandahl , Jorgensen Jens Otto Lunde

Objective: The short-term cardiovascular effects of continuous ghrelin infusion in healthy humans remain to be studied.Methods: Fifteen healthy, young and normal-weight men volunteered to participate in a randomized double-blind, placebo-controlled cross-over study. The local ethics committee approved the study. We used a constant infusion of human ghrelin at a rate of 5 pmol/kg body weight per minute for 180 minutes and measured peak left ventricular my...